Literature DB >> 26260128

Living conditions are associated with increased antibiotic resistance in community isolates of Escherichia coli.

Brenda O Nomamiukor1, Carolyne Horner2, Andrew Kirby3, Gareth J Hughes4.   

Abstract

OBJECTIVES: The objective of this study was to measure the associations between domains of deprivation and antibiotic resistance of Escherichia coli.
METHODS: Routine surveillance data for antibiotic susceptibility of E. coli isolates were obtained from urine specimens taken from patients presenting with suspected urinary tract infection in 2010-12 to healthcare practitioners based in the community in Leeds and Bradford. Eight antibiotics were included in the analyses. Postcodes were linked to lower super output areas (average populations of 1500). The 2010 Indices of Deprivation were used as neighbourhood characteristics for each lower super output area. Multilevel logistic regression models were used to estimate the independent effect of structural components on the odds of resistance to each antibiotic.
RESULTS: With respect to living conditions, residence in the most-deprived areas compared with the least-deprived areas was associated with increased odds of antibiotic resistance for all eight antibiotics analysed. The magnitude of these associations included an OR of 2.04 (95% CI 1.03-3.07) for cefalexin, 2.16 (95% CI 1.16-4.05) for ciprofloxacin, 2.47 (95% CI 1.08-5.66) for nitrofurantoin and 1.33 (95% CI 1.07-1.75) for trimethoprim.
CONCLUSIONS: Social deprivation in the form of living conditions is associated with increased antibiotic resistance for E. coli. This evidence suggests there is a need for further individual-level studies to explore the potential mechanism for these associations.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26260128     DOI: 10.1093/jac/dkv229

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Socioeconomic factors associated with antimicrobial resistance of Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli in Chilean hospitals (2008-2017).

Authors:  Kasim Allel; Patricia García; Jaime Labarca; José M Munita; Magdalena Rendic; Eduardo A Undurraga
Journal:  Rev Panam Salud Publica       Date:  2020-09-23

Review 2.  Investigating the impact of poverty on colonization and infection with drug-resistant organisms in humans: a systematic review.

Authors:  Vivian Alividza; Victor Mariano; Raheelah Ahmad; Esmita Charani; Timothy M Rawson; Alison H Holmes; Enrique Castro-Sánchez
Journal:  Infect Dis Poverty       Date:  2018-08-17       Impact factor: 4.520

3.  Correlation of antimicrobial prescription rate and county income in medicare part D.

Authors:  Connor Volpi; Fadi Shehadeh; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France.

Authors:  Adeline Paumier; Antoine Asquier-Khati; Sonia Thibaut; Thomas Coeffic; Olivier Lemenand; Stéphanie Larramendy; Brice Leclère; Jocelyne Caillon; David Boutoille; Gabriel Birgand
Journal:  JAMA Netw Open       Date:  2022-09-01

5.  Sociodemographic Inequalities in Urinary Tract Infection in 2 Large California Health Systems.

Authors:  Joan A Casey; Kara E Rudolph; Sarah C Robinson; Katia Bruxvoort; Eva Raphael; Vennis Hong; Alice Pressman; Rachel Morello-Frosch; Rong X Wei; Sara Y Tartof
Journal:  Open Forum Infect Dis       Date:  2021-05-26       Impact factor: 3.835

6.  Prevalence of MDR organism (MDRO) carriage in children and their household members in Siem Reap Province, Cambodia.

Authors:  Shweta R Singh; Bunsoth Mao; Konstantin Evdokimov; Pisey Tan; Phana Leab; Rick Ong; Saphonn Vonthanak; Clarence C Tam; Li Yang Hsu; Paul Turner
Journal:  JAC Antimicrob Resist       Date:  2020-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.